Aicore Consumer Ukraine

Aicore Consumer Logo

Expert dialogue for women’s health: Aicore participates in the «Harmony of hormones» conference

On 19-20 June, Aicore participated in the scientific and practical conference «Harmony of hormones: the foundation of women’s reproductive health and the future of the nation», held in Odesa. The company presented its informational stands and joined the professional discussion of current challenges in modern gynecology.
The conference brought together leading experts in women’s health, who presented contemporary clinical approaches to patient management, discussed new guidelines, and shared practical experience.

One of the key highlights was the presentation by professor Tetiana Feoofanivna Tatarchuk, entitled «“First results: one year since the introduction of the clinical standard on “Benign breast diseases”». The address covered the outcomes of the standard’s first year of implementation and examined current approaches to managing patients with benign breast diseases, with particular focus on the tissue selectivity of tibolone (Aivial) and its effect on mammographic breast density.

A practical follow-up to the programme was the presentation by Iryna Vasylivna Doroshenko – a practising gynaecologist-endocrinologist, physician of the highest category, and Chief Medical Officer of the DIVA medical centres. Speaking on the topic «How to manage hot flushes when MHT is not on the treatment pathway», she addressed current options for managing women with vasomotor menopausal symptoms in cases where menopausal hormone therapy is not the optimal choice. She presented Remifemin – the number one herbal medicinal product in Europe – along with the possibilities of its application in this patient group.

Throughout the conference, the Aicore team worked at the information booth, where they had the opportunity to engage with physicians, address medical questions, and discuss contemporary approaches to supporting women’s health during menopause. Such interactions are an important element of open dialogue between the medical community and the pharmaceutical industry. Participation in the conference provided Aicore with yet another opportunity to support professional medical education, exchange experience with the expert community, and present modern solutions for the preservation of women’s health.